Discovery of parallel pathways of kanamycin biosynthesis allows antibiotic manipulation

Je Won Park, Sung Ryeol Park, Keshav Kumar Nepal, Ah Reum Han, Yeon Hee Ban, Young Ji Yoo, Eun Ji Kim, Eui Min Kim, Dooil Kim, Jae Kyung Sohng, Yeo Joon Yoon

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Kanamycin is one of the most widely used antibiotics, yet its biosynthetic pathway remains unclear. Current proposals suggest that the kanamycin biosynthetic products are linearly related via single enzymatic transformations. To explore this system, we have reconstructed the entire biosynthetic pathway through the heterologous expression of combinations of putative biosynthetic genes from Streptomyces kanamyceticus in the non-aminoglycoside-producing Streptomyces venezuelae. Unexpectedly, we discovered that the biosynthetic pathway contains an early branch point, governed by the substrate promiscuity of a glycosyltransferase, that leads to the formation of two parallel pathways in which early intermediates are further modified. Glycosyltransferase exchange can alter flux through these two parallel pathways, and the addition of other biosynthetic enzymes can be used to synthesize known and new highly active antibiotics. These results complete our understanding of kanamycin biosynthesis and demonstrate the potential of pathway engineering for direct in vivo production of clinically useful antibiotics and more robust aminoglycosides.

Original languageEnglish
Pages (from-to)843-852
Number of pages10
JournalNature Chemical Biology
Volume7
Issue number11
DOIs
Publication statusPublished - 2011 Jan 1
Externally publishedYes

Fingerprint

Kanamycin
Biosynthetic Pathways
Glycosyltransferases
Streptomyces
Anti-Bacterial Agents
Aminoglycosides
Enzymes
Genes

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Cite this

Park, J. W., Park, S. R., Nepal, K. K., Han, A. R., Ban, Y. H., Yoo, Y. J., ... Yoon, Y. J. (2011). Discovery of parallel pathways of kanamycin biosynthesis allows antibiotic manipulation. Nature Chemical Biology, 7(11), 843-852. https://doi.org/10.1038/nchembio.671

Discovery of parallel pathways of kanamycin biosynthesis allows antibiotic manipulation. / Park, Je Won; Park, Sung Ryeol; Nepal, Keshav Kumar; Han, Ah Reum; Ban, Yeon Hee; Yoo, Young Ji; Kim, Eun Ji; Kim, Eui Min; Kim, Dooil; Sohng, Jae Kyung; Yoon, Yeo Joon.

In: Nature Chemical Biology, Vol. 7, No. 11, 01.01.2011, p. 843-852.

Research output: Contribution to journalArticle

Park, JW, Park, SR, Nepal, KK, Han, AR, Ban, YH, Yoo, YJ, Kim, EJ, Kim, EM, Kim, D, Sohng, JK & Yoon, YJ 2011, 'Discovery of parallel pathways of kanamycin biosynthesis allows antibiotic manipulation', Nature Chemical Biology, vol. 7, no. 11, pp. 843-852. https://doi.org/10.1038/nchembio.671
Park, Je Won ; Park, Sung Ryeol ; Nepal, Keshav Kumar ; Han, Ah Reum ; Ban, Yeon Hee ; Yoo, Young Ji ; Kim, Eun Ji ; Kim, Eui Min ; Kim, Dooil ; Sohng, Jae Kyung ; Yoon, Yeo Joon. / Discovery of parallel pathways of kanamycin biosynthesis allows antibiotic manipulation. In: Nature Chemical Biology. 2011 ; Vol. 7, No. 11. pp. 843-852.
@article{a7a120810f2f44f686ec72577525f9a1,
title = "Discovery of parallel pathways of kanamycin biosynthesis allows antibiotic manipulation",
abstract = "Kanamycin is one of the most widely used antibiotics, yet its biosynthetic pathway remains unclear. Current proposals suggest that the kanamycin biosynthetic products are linearly related via single enzymatic transformations. To explore this system, we have reconstructed the entire biosynthetic pathway through the heterologous expression of combinations of putative biosynthetic genes from Streptomyces kanamyceticus in the non-aminoglycoside-producing Streptomyces venezuelae. Unexpectedly, we discovered that the biosynthetic pathway contains an early branch point, governed by the substrate promiscuity of a glycosyltransferase, that leads to the formation of two parallel pathways in which early intermediates are further modified. Glycosyltransferase exchange can alter flux through these two parallel pathways, and the addition of other biosynthetic enzymes can be used to synthesize known and new highly active antibiotics. These results complete our understanding of kanamycin biosynthesis and demonstrate the potential of pathway engineering for direct in vivo production of clinically useful antibiotics and more robust aminoglycosides.",
author = "Park, {Je Won} and Park, {Sung Ryeol} and Nepal, {Keshav Kumar} and Han, {Ah Reum} and Ban, {Yeon Hee} and Yoo, {Young Ji} and Kim, {Eun Ji} and Kim, {Eui Min} and Dooil Kim and Sohng, {Jae Kyung} and Yoon, {Yeo Joon}",
year = "2011",
month = "1",
day = "1",
doi = "10.1038/nchembio.671",
language = "English",
volume = "7",
pages = "843--852",
journal = "Nature Chemical Biology",
issn = "1552-4450",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Discovery of parallel pathways of kanamycin biosynthesis allows antibiotic manipulation

AU - Park, Je Won

AU - Park, Sung Ryeol

AU - Nepal, Keshav Kumar

AU - Han, Ah Reum

AU - Ban, Yeon Hee

AU - Yoo, Young Ji

AU - Kim, Eun Ji

AU - Kim, Eui Min

AU - Kim, Dooil

AU - Sohng, Jae Kyung

AU - Yoon, Yeo Joon

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Kanamycin is one of the most widely used antibiotics, yet its biosynthetic pathway remains unclear. Current proposals suggest that the kanamycin biosynthetic products are linearly related via single enzymatic transformations. To explore this system, we have reconstructed the entire biosynthetic pathway through the heterologous expression of combinations of putative biosynthetic genes from Streptomyces kanamyceticus in the non-aminoglycoside-producing Streptomyces venezuelae. Unexpectedly, we discovered that the biosynthetic pathway contains an early branch point, governed by the substrate promiscuity of a glycosyltransferase, that leads to the formation of two parallel pathways in which early intermediates are further modified. Glycosyltransferase exchange can alter flux through these two parallel pathways, and the addition of other biosynthetic enzymes can be used to synthesize known and new highly active antibiotics. These results complete our understanding of kanamycin biosynthesis and demonstrate the potential of pathway engineering for direct in vivo production of clinically useful antibiotics and more robust aminoglycosides.

AB - Kanamycin is one of the most widely used antibiotics, yet its biosynthetic pathway remains unclear. Current proposals suggest that the kanamycin biosynthetic products are linearly related via single enzymatic transformations. To explore this system, we have reconstructed the entire biosynthetic pathway through the heterologous expression of combinations of putative biosynthetic genes from Streptomyces kanamyceticus in the non-aminoglycoside-producing Streptomyces venezuelae. Unexpectedly, we discovered that the biosynthetic pathway contains an early branch point, governed by the substrate promiscuity of a glycosyltransferase, that leads to the formation of two parallel pathways in which early intermediates are further modified. Glycosyltransferase exchange can alter flux through these two parallel pathways, and the addition of other biosynthetic enzymes can be used to synthesize known and new highly active antibiotics. These results complete our understanding of kanamycin biosynthesis and demonstrate the potential of pathway engineering for direct in vivo production of clinically useful antibiotics and more robust aminoglycosides.

UR - http://www.scopus.com/inward/record.url?scp=80054858740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054858740&partnerID=8YFLogxK

U2 - 10.1038/nchembio.671

DO - 10.1038/nchembio.671

M3 - Article

VL - 7

SP - 843

EP - 852

JO - Nature Chemical Biology

JF - Nature Chemical Biology

SN - 1552-4450

IS - 11

ER -